Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
73°
Clear
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Edesa Biotech Inc
(NQ:
EDSA
)
4.450
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Edesa Biotech Inc
< Previous
1
2
3
4
5
Next >
Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate
September 28, 2023
Via
ACCESSWIRE
Edesa Biotech Reports Fiscal Third Quarter 2023 Results
August 09, 2023
Via
ACCESSWIRE
Edesa Biotech to Participate in Upcoming Canaccord Genuity Growth Conference
July 26, 2023
Via
ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
July 17, 2023
It's time to start off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday!
Via
InvestorPlace
Edesa Biotech's COVID-19 Candidate Restraints Inflammation From Influenza, Other Pathogens In Preclinical Studies
June 28, 2023
Edesa Biotech Inc (NASDAQ: EDSA) released findings from an in vitro study involving its monoclonal antibody candidate, paridiprubart.
Via
Benzinga
Edesa Biotech's Dermatitis Study Data Fails To Cheer Investors
January 17, 2023
Via
Benzinga
Edesa Biotech's ARDS Drug Inhibits Inflammation from Influenza and Other Pathogens
June 28, 2023
Via
ACCESSWIRE
Edesa Biotech Appoints Biotech Deal Veteran to CFO Role
June 27, 2023
Via
ACCESSWIRE
Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results
May 11, 2023
Via
ACCESSWIRE
Edesa Biotech to Participate in Swiss Biotech Day
April 20, 2023
Via
ACCESSWIRE
The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug Candidate
April 04, 2023
Via
ACCESSWIRE
Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Disease Conference
March 23, 2023
Via
ACCESSWIRE
Edesa Biotech to Present Favorable Dermatitis Drug Results at American Academy of Dermatology Association Annual Meeting
March 16, 2023
Via
ACCESSWIRE
Edesa Biotech and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug Study
March 15, 2023
Via
ACCESSWIRE
Edesa Biotech Reports Fiscal 1st Quarter 2023 Results
February 10, 2023
Via
ACCESSWIRE
Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study
February 01, 2023
Via
ACCESSWIRE
Why Arcimoto Shares Are Trading Lower By 44%; Here Are 20 Stocks Moving Premarket
January 18, 2023
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) rose 41.5% to $0.3255 in pre-market trading after gaining 8% on Tuesday.
Via
Benzinga
Nasdaq Edges Higher; Neovasc Shares Jump
January 17, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Tuesday.
Via
Benzinga
Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views
January 17, 2023
U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 300 points on Tuesday.
Via
Benzinga
Dow Drops Over 150 Points; Goldman Sachs Profit Misses Expectations
January 17, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Tuesday.
Via
Benzinga
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 17, 2023
Gainers Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program...
Via
Benzinga
Edesa Biotech Reports Topline Phase 2b Results for Dermatology Drug
January 17, 2023
Via
ACCESSWIRE
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
December 23, 2022
Gainers
Via
Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
December 22, 2022
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
FDA Grants Fast Track to Edesa Biotech's ARDS Drug Candidate
December 20, 2022
Via
ACCESSWIRE
Edesa Biotech Reports Fiscal Year 2022 Results
December 16, 2022
Via
ACCESSWIRE
Edesa Biotech to Participate in the 2022 Cantor Fitzgerald Dermatology Conference
December 02, 2022
Via
ACCESSWIRE
Edesa Biotech Announces Closing of $3.0 Million Private Placement Priced At-the-Market
November 03, 2022
Via
ACCESSWIRE
What Is Going on With Edesa Biotech (EDSA) Stock Today?
September 30, 2022
Edesa Biotech released encouraging Phase 2 results for its respiratory-syndrome-targeting antibody, thus initially boosting EDSA stock.
Via
InvestorPlace
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday
October 03, 2022
Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.